• TechCrunch
• CrunchBase
• More
  • TechCrunch UK
  • TechCrunch France
  • TechCrunch Japan

CalciMedica

edit

CalciMedica was founded in December 2006 by Gonul Velicelebi, Ph.D., Kenneth Stauderman, Ph.D. and Jack Roos, Ph.D., all previously with TorreyPines Therapeutics, where they discovered the role of STIM1 in the Icrac pathway in 2003. Other co-founders, all from the CBR Institute, include Anjana Rao, Ph.D., Patrick Hogan, Ph.D. and Stefan Feske, M.D, who identified Orai1 as the CRAC channel subunit in 2006.

Milestones

edit

• 
  CalciMedica added Jack Roos as Co-founder and Director, Biology.
  Posted 6/15/09 at 7:28pm
• 
  CalciMedica added Jeffrey P. Whitten as Vice President, Chemistry .
  Posted 6/15/09 at 7:28pm
• 
  CalciMedica added Gonul Velicelebi as Founder, President and Chief Executive Officer.
  Posted 6/15/09 at 7:28pm
• 
  CalciMedica received $6M in Unattributed funding. (2/17/11)
  Posted 2/17/11 at 9:53pm via dowjones.com
• 
  CalciMedica received $1.5M in Series A funding. (7/31/07)
  Posted 3/19/10 at 5:18am via venturebeat.com
• 
  CalciMedica received $5.5M in Series B funding. (8/1/07)
  Posted 3/16/10 at 8:08pm
• 
  CalciMedica received $12M in Series C funding. (12/15/09)
  Posted 12/16/09 at 3:20am via finsmes.com
• 
  CalciMedica received $4M in Series C funding. (1/4/09)
  Posted 6/15/09 at 7:24pm via onbiovc.com

Videos

Screenshots

edit

Above: CalciMedica
Uploaded: 6/16/09

Sources

1. CalciMedica raises $1.5M for inflammatory disease (venturebeat.com) [edit]
2. Cap Funding Report [edit]
3. CalciMedica, Inc.: Series C $4M (onbiovc.com) [edit]
4. CalciMedica Closes Second Tranche of $12M Series C Financing (finsmes.com) [edit]
5. CalciMedica Raises $6M Financing Tranche, Launches Clinical Studies (fis.dowjones.com) [edit]